Jamaican fruit bats (Artibeus jamaicensis) competence for Ebola virus but not Marburg virus is driven by intrinsic differences in viral entry and IFN-I signaling antagonism.

Sarah Van Tol,Julia Port,Robert Fischer,Shane Gallogly,Trenton Bushmaker,Amanda Griffin,Jonathan E Schulz,Aaron B Carmody,Lara Myers,Dan Crowley,Caylee Falvo,Jade Riopelle,Arthur Wickenhagen,Chad Clancy,Jamie Lovaglio,Carl Shaia,Greg Saturday,Jessy Prado-Smith,Yi Hr,Justin Lack,Craig Martens,Sarah Anzick,Lon Kendall,Tony Schountz,Raina Plowright,Andrea Marzi,Vincent Munster

DOI: https://doi.org/10.1101/2024.10.17.618736

2024-10-19

Abstract:Ebola virus (EBOV) and Marburg virus (MARV) are zoonotic filoviruses that cause hemorrhagic fever in humans. Bat species in both Chiropteran suborders host filoviruses, suggesting that bats may have coevolved with this viral family. Correlative data implicate bats as natural EBOV hosts, but neither a full-length genome nor an EBOV isolate has been found in any bats sampled. Here, we modelled filovirus infection in the Jamaican fruit bat (JFB), Artibeus jamaicensis. Bats were inoculated with either EBOV or MARV through a combination of oral, intranasal, and subcutaneous routes. EBOV-infected bats supported systemic virus replication and shed infectious virus orally. In contrast, MARV replicated only transiently and was not shed. In vitro, JFB cells replicate EBOV more efficiently than MARV, and MARV infection induced innate antiviral responses that EBOV efficiently suppressed. Experiments using VSV pseudoparticles or replicating VSV expressing the EBOV or MARV glycoprotein demonstrated an advantage for EBOV entry and replication early, respectively, in JFB cells. Overall, this study describes filovirus species-specific phenotypes for both JFB and their cells.

Immunology

What problem does this paper attempt to address?

This paper aims to explore the differential infection capabilities of the Jamaican fruit bat (*Artibeus jamaicensis*) to Ebola virus (EBOV) and Marburg virus (MARV) and the underlying mechanisms. Specifically, the researchers hope to experimentally verify the following points: 1. **Virus Replication and Transmission**: Whether the Jamaican fruit bat can support the systemic replication of these two viruses, and how the viruses distribute and spread within the body after infection through different routes (such as oral, nasal, and subcutaneous injection). 2. **Virus Shedding**: Whether the infected Jamaican fruit bat will shed infectious viral particles through routes such as the oral cavity. 3. **Cellular Level Differences**: In in vitro experiments, whether there are differences in the replication efficiency of EBOV and MARV in the cells of the Jamaican fruit bat, and what the specific reasons for these differences are. 4. **Immune Response**: The differences in the immune response of the Jamaican fruit bat to these two viruses, particularly the role of the type I interferon (IFN-I) signaling pathway. Through these studies, the authors hope to reveal the different sensitivities of the Jamaican fruit bat to EBOV and MARV infections, thereby providing scientific evidence for further understanding the transmission mechanisms of these viruses in their natural hosts. This not only helps explain why certain bat species can become natural hosts for specific viruses but also provides important reference information for developing strategies to control these viruses.

Jamaican fruit bats (Artibeus jamaicensis) competence for Ebola virus but not Marburg virus is driven by intrinsic differences in viral entry and IFN-I signaling antagonism.

Marburg and Ebola Virus Infections Elicit a Complex, Muted Inflammatory State in Bats

Deciphering bat influenza H18N11 infection dynamics in male Jamaican fruit bats on a single-cell level

Regulatory T cell-like response to SARS-CoV-2 in Jamaican fruit bats (Artibeus jamaicensis) transduced with human ACE2

Selective replication and vertical transmission of Ebola virus in experimentally infected Angolan free-tailed bats

Discrimination of Jamaican fruit bat lymphocytes by flow cytometry

Bats generate lower affinity but higher diversity antibody responses than those of mice, but pathogen-binding capacity increases if protein is restricted in their diet

Structural and Molecular Basis for Ebola Virus Neutralization by Protective Human Antibodies

Asymptomatic Infection of Marburg Virus Reservoir Bats Is Explained by a Strategy of Immunoprotective Disease Tolerance

Coordinated inflammatory responses dictate Marburg virus control by reservoir bats

Tolerance and Persistence of Ebola Virus in Primary Cells from Mops condylurus, a Potential Ebola Virus Reservoir

Clinical, Histopathologic, and Immunohistochemical Characterization of Experimental Marburg Virus Infection in A Natural Reservoir Host, the Egyptian Rousette Bat (Rousettus aegyptiacus)

Peripheral immune responses to filoviruses in a reservoir versus spillover hosts reveal transcriptional correlates of disease

Jamaican fruit bats mount a stable and highly neutralizing antibody response after bat influenza virus infection

Dose-dependent response to infection with Ebola virus in the ferret model and evidence of viral evolution in the eye.

Dendritic Cells Generated From Mops condylurus, a Likely Filovirus Reservoir Host, Are Susceptible to and Activated by Zaire Ebolavirus Infection

Undiscovered Bat Hosts of Filoviruses

The Lifecycle of the Ebola Virus in Host Cells.

Metagenomics-enabled reverse-genetics assembly and characterization of myotis bat morbillivirus

Adipose Tissues from Human and Bat-Derived Cell Lines Support Ebola Virus Infection

Stimulation of Ebola virus production from persistent infection through activation of the Ras/MAPK pathway